89bio, Inc. (NASDAQ:ETNB – Get Rating)’s stock price was up 7.7% during trading on Monday . The stock traded as high as $16.71 and last traded at $16.71. Approximately 321,227 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 1,993,399 shares. The stock had previously closed at $15.52. […]
89bio, Inc. (NASDAQ:ETNB – Get Rating) CFO Ryan Martins sold 8,721 shares of the firm’s stock in a transaction on Tuesday, April 4th. The stock was sold at an average price of $14.95, for a total value of $130,378.95. Following the completion of the transaction, the chief financial officer now owns 53,578 shares of the […]
89bio, Inc. (NASDAQ:ETNB – Get Rating) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 5,590,000 shares, an increase of 8.5% from the February 28th total of 5,150,000 shares. Based on an average daily volume of 1,920,000 shares, the short-interest […]
89bio, Inc. (NASDAQ:ETNB – Get Rating) – Analysts at SVB Leerink increased their Q1 2023 earnings per share estimates for 89bio in a research report issued to clients and investors on Tuesday, March 28th. SVB Leerink analyst T. Smith now expects that the company will post earnings per share of ($0.45) for the quarter, up […]
89bio, Inc. (NASDAQ:ETNB – Get Rating) Director Ra Capital Management, L.P. bought 2,461,538 shares of the business’s stock in a transaction on Friday, March 24th. The stock was bought at an average price of $16.25 per share, for a total transaction of $39,999,992.50. Following the transaction, the director now directly owns 11,081,584 shares of the […]